A small pilot study provides an early glimpse of how some veterans struggling with PTSD may benefit from one simple, inexpensive treatment involving nitrous oxide, commonly known as laughing gas.
To address postoperative muscle pain in patients undergoing abdominal surgery, researchers developed a new method of effective pain control called needle electrical twitch obtaining intramuscular stimulation (NETOIMS).
Choice and control are important factors for ensuring a positive childbirth experience, yet until recently, little was known about the impact of alternative administrations of fentanyl -- one of the pain relief drugs used during labour- on both mother and baby.
The aim of this study was to compare the effects of 4-weeks of Traditional Resistance Training versus Plyometric Jump Training programs on the muscular fitness of sedentary and physically inactive participants.
Summertime means Americans spend more time around grills, firepits, and fireworks, increasing their risk for fire-related burn injuries. While 53% of Americans say they know some or a lot about burn injuries and treatment, many mistakenly underestimate their risks with these activities, according to a new Arizona Burn Center at Valleywise Health/Ipsos survey. Only 11% know that fire-flame injuries such as those from a firepit or grill are the most common types of burn injuries.
Neuroscientists of the University of Zurich shed a new light on the mechanisms responsible for familial migraine: They show that a genetic dysfunction in specific brain cells of the cingulate cortex area strongly influences head pain occurrence.
A team of international researchers has learned that dose escalation of hydroxyurea treatment for children in Uganda with sickle cell anemia is more effective and has similar side effects than a lower fixed dose of the same drug. They report in the New England Journal of Medicine that the clinical research milestone removes a major barrier to broadly expand the use of hydroxyurea in low-resource regions like sub-Saharan Africa.
Ben-Gurion University researcher Levy-Tzedek and her team discovered that a single, 60-minute interaction with PARO actually improved mood as well as reduced mild or severe pain. When participants touched PARO, they experienced greater pain reduction than when it was simply present in their room.
A new study has found that tanezumab, a monoclonal antibody that inhibits nerve activity, provides relief in patients with chronic low back pain, one of the leading reasons why people seek medical care and the number one cause of disability worldwide.
Researchers at the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) developed LIH383, a novel molecule that binds to and blocks a previously unknown opioid receptor in the brain, thereby modulating the levels of opioid peptides produced in the central nervous system (CNS) and potentiating their natural painkilling and antidepressant properties. These findings were published on June 19th in the prestigious international journal 'Nature Communications'.